ATE9906T1 - Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form. - Google Patents
Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form.Info
- Publication number
- ATE9906T1 ATE9906T1 AT81104558T AT81104558T ATE9906T1 AT E9906 T1 ATE9906 T1 AT E9906T1 AT 81104558 T AT81104558 T AT 81104558T AT 81104558 T AT81104558 T AT 81104558T AT E9906 T1 ATE9906 T1 AT E9906T1
- Authority
- AT
- Austria
- Prior art keywords
- cocytotaxin
- anaphylatoxin
- proteins
- preparations
- obtaining
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 238000002360 preparation method Methods 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 102000004506 Blood Proteins Human genes 0.000 abstract 3
- 108010017384 Blood Proteins Proteins 0.000 abstract 3
- 239000012141 concentrate Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 238000000926 separation method Methods 0.000 abstract 3
- 238000004587 chromatography analysis Methods 0.000 abstract 2
- 239000000470 constituent Substances 0.000 abstract 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 abstract 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000002808 molecular sieve Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803022914 DE3022914A1 (de) | 1980-06-19 | 1980-06-19 | Verfahren zurgewinnung eines anaphylatoxin und cocytotaxin enthaltenden leukotaxinpraeparates sowie von anaphylatoxin und cocytotaxin in molekular einheitlicher form |
| EP81104558A EP0042560B1 (de) | 1980-06-19 | 1981-06-12 | Verfahren zum Herstellen und Erhalten von Anaphylatoxin und Cocytotaxin enthaltenden Leukotaxin-Präparaten und von Anaphylatoxin- und Cocytotaxin-Proteinen in einer molekular homogenen und biologisch aktiven Form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE9906T1 true ATE9906T1 (de) | 1984-11-15 |
Family
ID=6104950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT81104558T ATE9906T1 (de) | 1980-06-19 | 1981-06-12 | Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form. |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US4495096A (de) |
| EP (1) | EP0042560B1 (de) |
| JP (1) | JPS5731621A (de) |
| AT (1) | ATE9906T1 (de) |
| DE (2) | DE3022914A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE940698L (en) * | 1984-04-05 | 1985-10-05 | Univ Missouri | Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant |
| JPS61235752A (ja) * | 1985-04-11 | 1986-10-21 | Asahi Optical Co Ltd | 細胞分離材、分離器および分離方法 |
| JP2536749B2 (ja) * | 1986-03-22 | 1996-09-18 | 旭光学工業株式会社 | 細胞分離剤、その製造方法及びそれを使用した細胞分離器並びにそれを使用した免疫抑制性リンパ球、及び／又は免疫抑制因子産生細胞の除去方法 |
| US5006259A (en) * | 1988-03-21 | 1991-04-09 | E. I. Du Pont De Nemours And Company | Process and means for use of anaphylatoxin adsorbents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2710293A (en) * | 1953-10-30 | 1955-06-07 | Olin Mathieson | Blood fractionation |
-
1980
- 1980-06-19 DE DE19803022914 patent/DE3022914A1/de not_active Withdrawn
-
1981
- 1981-06-12 AT AT81104558T patent/ATE9906T1/de not_active IP Right Cessation
- 1981-06-12 EP EP81104558A patent/EP0042560B1/de not_active Expired
- 1981-06-12 DE DE8181104558T patent/DE3166700D1/de not_active Expired
- 1981-06-18 US US06/275,014 patent/US4495096A/en not_active Expired - Fee Related
- 1981-06-19 JP JP9516581A patent/JPS5731621A/ja active Pending
-
1984
- 1984-04-06 US US06/597,810 patent/US4610815A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5731621A (en) | 1982-02-20 |
| EP0042560A2 (de) | 1981-12-30 |
| EP0042560A3 (en) | 1982-06-09 |
| US4610815A (en) | 1986-09-09 |
| EP0042560B1 (de) | 1984-10-17 |
| DE3022914A1 (de) | 1981-12-24 |
| DE3166700D1 (en) | 1984-11-22 |
| US4495096A (en) | 1985-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4309418A (en) | Anti-tumor agent from human serum and process | |
| DE2720704C2 (de) | Neues Glycoprotein, Verfahren zu seiner Herstellung und seine Verwendung | |
| DE69727595D1 (de) | Verfahren zur herstellung eines extraktes des plättchenwachstumsfaktors für zubereitungen zur wundheilung | |
| DE3484673D1 (de) | Digitalis-antikoerper, verfahren zu ihrer herstellung und ihre verwendung zur therapie von digitalis-intoxikationen. | |
| FI101381B1 (fi) | Nukleotidisekvenssi ja menetelmä polypeptidin HSA(1-387) tuottamiseksi | |
| DE3773963D1 (de) | Verfahren zur herstellung von reifem, menschlichem serum-albumin. | |
| EP0000134B1 (de) | Glykoprotein, Verfahren zu seiner Herstellung, seine Verwendung zur Gewinnung von Antiserum sowie das Antiserum | |
| SE8602877L (sv) | Extraktionsforfarande for mjolkproteiner, produkter, anvendning av forfarandet och farmaceutiska kompositioner | |
| DE68915226T2 (de) | Thrombin bindende Substanz und Verfahren zu ihrer Herstellung. | |
| ES534008A0 (es) | Procedimiento de separacion de las principales proteinas de la sangre hemolizada | |
| EP0139975B1 (de) | Verfahren zur Pasteurisierung von Humanplasma | |
| ATE101345T1 (de) | Selektive entfernung von immunkomplexen. | |
| ATE9906T1 (de) | Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form. | |
| KR960009052B1 (en) | Simultaneous preparation process of useful proteins from human urine | |
| Sehon et al. | Electrophoretic separation of skin-sensitizing antibody from the sera of ragweed-sensitive patients | |
| EP0146107A2 (de) | Verfahren zur nacheinanderfolgenden Herstellung von humanem Leukozyteninterferon und humanem Gamma-Interferon | |
| AT384032B (de) | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) | |
| Kudo et al. | Characterization of tumour cell aggregation promoting factor from rat ascites hepatoma cells: Separation of two factors with different antigenic property | |
| Miribel et al. | The use of dye-ligand affinity chromatography for the purification of non-enzymatic human plasma proteins | |
| RU98105411A (ru) | Способ получения препарата альфа-фетопротеина | |
| ATE82471T1 (de) | Verfahren zur abtrennung bestimmter proteine aus molke. | |
| US3993585A (en) | Elevated human lipids control | |
| GB1522600A (en) | Proteins | |
| ATE106893T1 (de) | Verfahren zur herstellung von aktiviertem protein c. | |
| AT391482B (de) | Verfahren zur industriellen herstellung von hochreinem menschlichem leukozyteninterferon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |